Causal associations between risk factors and common diseases inferred from GWAS summary data

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Zhu, Zhihong ^a   Zheng, Zhili ^a,b   Zhang, Futao ^a   Wu, Yang ^a   Trzaskowski, Maciej ^a   Maier, Robert ^a   Robinson, Matthew R ^a   McGrath, John J ^a,c,d   Visscher, Peter M ^a   Wray, Naomi R ^a   Yang, Jian ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD; BODY MASS; DIABETES; DISEASE INCIDENCE; EDUCATION; GENOME; INDEX METHOD; NERVOUS SYSTEM DISORDER; RISK FACTOR; SERUM;

ALZHEIMER DISEASE; ARTICLE; ASTHMA; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DERMATOPHYTOSIS; DYSLIPIDEMIA; GENE LINKAGE DISEQUILIBRIUM; GENETIC CORRELATION; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HEALTH HAZARD; HEREDITY; HERITABILITY; HUMAN; HYPERTENSION; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; PERIPHERAL VASCULAR DISEASE; PHENOTYPE; PLEIOTROPY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; BLOOD; DISEASES; GENETICS; PROCEDURES;

ALZHEIMER DISEASE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 85040786442     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-02317-2     Document Type: Article

References (56)

1. Knoops, K. T. et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292, 1433-1439 (2004).
2. Danaei, G. et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6, e1000058 (2009).
3. Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C. & Heath, C. W. Jr. Bodymass index and mortality in a prospective cohort of U. S. adults. N. Engl. J. Med 341, 1097-1105 (1999).
4. Hu, F. B. et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345, 790-797 (2001).
5. Kannel, W. B., Castelli, W. P., Gordon, T. & McNamara, P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 74, 1-12 (1971).
6. The Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 251, 351-364 (1984).
7. Baigent, C. et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 366, 1267-1278 (2005).
8. Pickrell J. Fulfilling the promise of Mendelian randomization. bioRxiv https:// doi. org/10. 1101/018150 (2015).
9. Smith, G. D. & Ebrahim, S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1-22 (2003).
10. Lawlor, D. A., Harbord, R. M., Sterne, J. A., Timpson, N. & Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133-1163 (2008).
11. Hernan, M. A. & Robins, J. M. Instruments for causal inference: an epidemiologist's dream? Epidemiology 17, 360-372 (2006).
12. Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658-665 (2013).
13. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512-525 (2015).
14. Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G. & Thompson, S. G., EPIC-InterAct Consortium. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543-552 (2015).
15. Evans, D. M. & Davey Smith, G. Mendelian randomization: new applications in the coming age of hypothesis-free causality. Annu. Rev. Genom. Hum. Genet. 16, 327-350 (2015).
16. Pickrell, J. K., Berisa, T., Liu, J. Z., Segurel, L., Tung, J. Y. & Hinds, D. A. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709-717 (2016).
17. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481-487 (2016).
18. Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat. Med. 35, 1880-1906 (2016).
19. Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89-R98 (2014).
20. Do, R. et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345-1352 (2013).
21. Voight, B. F. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380, 572-580 (2012).
22. Visscher, P. M. & Yang, J. A plethora of pleiotropy across complex traits. Nat. Genet. 48, 707-708 (2016).
23. Aschard, H., Vilhjalmsson, B. J., Joshi, A. D., Price, A. L. & Kraft, P. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am. J. Hum. Genet. 96, 329-339 (2015).
24. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206 (2015).
25. Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187-196 (2015).
26. Global Lipids Genetics Consortium et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013).
27. Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
28. Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer data sets. Gigascience 4, 7 (2015).
29. Banda, Y. et al. Characterizing race/ethnicity and genetic ancestry for 100, 000 subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort. Genetics 200, 1285-1295 (2015).
30. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236-1241 (2015).
31. de Bakker, P. I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122-R128 (2008).
32. Fritsche, L. G. et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 48, 134-143 (2016).
33. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am. J. Epidemiol. 129, 687-702 (1989).
34. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
35. Look, A. R. G. & Wing, R. R. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch. Intern. Med. 170, 1566-1575 (2010).
36. Granell, R. et al. Effects of BMI, fat mass, and lean mass on asthma in childhood: a Mendelian randomization study. PLoS Med. 11, e1001669 (2014).
37. Barrera, G. et al. A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition 20, 769-771 (2004).
38. Garland, D. E., Adkins, R. H., Kushwaha, V. & Stewart, C. Risk factors for osteoporosis at the knee in the spinal cord injury population. J. Spinal Cord. Med. 27, 202-206 (2004).
39. Sattar, N. et al. Statins and risk of incident diabetes: a collaborative metaanalysis of randomised statin trials. Lancet 375, 735-742 (2010).
40. Rader, D. J. & Hovingh, G. K. HDL and cardiovascular disease. Lancet 384, 618-625 (2014).
41. Emerging Risk Factors Colaboration et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993-2000 (2009).
42. Burgess, S. & Davey Smith, G. Mendelian randomization implicates highdensity lipoprotein cholesterol-associated mechanisms in etiology of age-related macular degeneration. Ophthalmology 124, 1165-1174 (2017).
43. Pennington, K. L. & DeAngelis, M. M. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis. 3, 34 (2016).
44. van Leeuwen, R. et al. Cholesterol and age-related macular degeneration: is there a link? Am. J. Ophthalmol. 137, 750-752 (2004).
45. Yip, J. L. et al. Cross sectional and longitudinal associations between cardiovascular risk factors and age related macular degeneration in the EPICNorfolk Eye Study. PLoS ONE 10, e0132565 (2015).
46. Collins, R. et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335, 827-838 (1990).
47. Fox, K. M., EURopean Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362, 782-788 (2003).
48. Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173-1186 (2014).
49. Okbay, A. et al. Genome-wide association study identifies 74 loci associated with educational attainment. Nature 533, 539-542 (2016).
50. Stern, Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 11, 1006-1012 (2012).
51. Wooldridge, J. X. Introductory Econometrics: A Modern Approach (Nelson Education, Toronto, ON, 2015).
52. Burgess, S., Bowden, J., Fall, T., Ingelsson, E. & Thompson, S. G. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology 28, 30-42 (2017).
53. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369-375 (2012).
54. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291-295 (2015).
55. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
56. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76-82 (2011).